BIOMARIN PHARMACEUTICAL INC Quarterly Unrecognized Tax Benefits in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
Biomarin Pharmaceutical Inc quarterly Unrecognized Tax Benefits history and growth rate from Q4 2010 to Q4 2023.
  • Biomarin Pharmaceutical Inc Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $277M, a 19.2% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $277M +$44.6M +19.2% Dec 31, 2023 10-K 2024-02-26
Q4 2022 $233M +$27.8M +13.5% Dec 31, 2022 10-K 2024-02-26
Q4 2021 $205M +$22.5M +12.3% Dec 31, 2021 10-K 2024-02-26
Q4 2020 $183M +$13.8M +8.19% Dec 31, 2020 10-K 2023-02-27
Q4 2019 $169M +$21.3M +14.4% Dec 31, 2019 10-K 2022-02-25
Q4 2018 $147M +$34M +29.9% Dec 31, 2018 10-K 2021-02-26
Q4 2017 $113M +$10.3M +9.96% Dec 31, 2017 10-K 2020-02-27
Q4 2016 $103M +$16.5M +19% Dec 31, 2016 10-K 2019-02-28
Q4 2015 $86.7M +$15.1M +21% Dec 31, 2015 10-K 2018-02-26
Q4 2014 $71.7M +$20.8M +41% Dec 31, 2014 10-K 2017-02-27
Q4 2013 $50.8M +$7.28M +16.7% Dec 31, 2013 10-K 2016-02-29
Q4 2012 $43.5M +$7.18M +19.8% Dec 31, 2012 10-K 2015-03-02
Q4 2011 $36.4M +$5.24M +16.8% Dec 31, 2011 10-K 2014-02-26
Q4 2010 $31.1M Dec 31, 2010 10-K 2013-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.